Glutamate and glutamine: a review of in vivo MRS in the human brain

被引:210
作者
Ramadan, Saadallah [1 ]
Lin, Alexander [2 ]
Stanwell, Peter [1 ]
机构
[1] Univ Newcastle, Sch Hlth Sci, Fac Hlth & Med, Callaghan, NSW 2308, Australia
[2] Harvard Univ, Brigham & Womens Hosp, Dept Radiol, Ctr Clin Spect,Med Sch, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
human; in vivo; glutamate; glutamine; MRS; C-13; one dimensional; two dimensional; MAGNETIC-RESONANCE-SPECTROSCOPY; CHRONIC HEPATIC-ENCEPHALOPATHY; TRICARBOXYLIC-ACID CYCLE; C-13; MRS; H-1-NMR SPECTROSCOPY; PROTON SPECTROSCOPY; AMINO-ACIDS; METABOLITE CONCENTRATIONS; DIFFERENCE SPECTROSCOPY; ANTERIOR CINGULATE;
D O I
10.1002/nbm.3045
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Our understanding of the roles that the amino acids glutamate (Glu) and glutamine (Gln) play in the mammalian central nervous system has increased rapidly in recent times. Many conditions are known to exhibit a disturbance in Glu-Gln equilibrium, and the exact relationships between these changed conditions and these amino acids are not fully understood. This has led to increased interest in Glu/Gln quantitation in the human brain in an array of conditions (e.g. mental illness, tumor, neuro-degeneration) as well as in normal brain function. Accordingly, this review has been undertaken to describe the increasing number of in vivo techniques available to study Glu and Gln separately, or pooled as Glx'. The present MRS methods used to assess Glu and Gln vary in approach, complexity, and outcome, thus the focus of this review is on a description of MRS acquisition approaches, and an indication of relative utility of each technique rather than brain pathologies associated with Glu and/or Gln perturbation. Consequently, this review focuses particularly on (1) one-dimensional H-1 MRS, (2) two-dimensional H-1 MRS, and (3) one-dimensional C-13 MRS techniques. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:1630 / 1646
页数:17
相关论文
共 149 条
  • [41] Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO
  • [42] 2-V
  • [43] Neurological implications of urea cycle disorders
    Gropman, A. L.
    Summar, M.
    Leonard, J. V.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 (06) : 865 - 879
  • [44] Broadband decoupled, H-1-localized C-13 MRS of the human brain at 4 Tesla
    Gruetter, R
    Adriany, G
    Merkle, H
    Andersen, PM
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1996, 36 (05) : 659 - 664
  • [45] Localized in vivo 13C-NMR of glutamate metabolism in the human brain:: Initial results at 4 Tesla
    Gruetter, R
    Seaquist, ER
    Kim, S
    Ugurbil, K
    [J]. DEVELOPMENTAL NEUROSCIENCE, 1998, 20 (4-5) : 380 - 388
  • [46] GRUETTER R, 1994, J NEUROCHEM, V63, P1377
  • [47] Quantification of glutamate and glutamine using constant-time point-resolved spectroscopy at 3 T
    Gu, Meng
    Zahr, Natalie M.
    Spielman, Daniel M.
    Sullivan, Edith V.
    Pfefferbaum, Adolf
    Mayer, Dirk
    [J]. NMR IN BIOMEDICINE, 2013, 26 (02) : 164 - 172
  • [48] Time-resolved functional 1H MR spectroscopic detection of glutamate concentration changes in the brain during acute heat pain stimulation
    Gussew, Alexander
    Rzanny, Reinhard
    Erdtel, Marko
    Scholle, Hans C.
    Kaiser, Werner A.
    Mentzel, Hans J.
    Reichenbach, Juergen R.
    [J]. NEUROIMAGE, 2010, 49 (02) : 1895 - 1902
  • [49] A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging
    Haga, Kristin K.
    Khor, Yuet Peng
    Farrall, Andrew
    Wardlaw, Joanna M.
    [J]. NEUROBIOLOGY OF AGING, 2009, 30 (03) : 353 - 363
  • [50] Optimized Glutamate Detection at 3T
    Hancu, Ileana
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 30 (05) : 1155 - 1162